Banque Transatlantique’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.75K Buy
171
+60
+54% +$717 ﹤0.01% 479
2026
Q1
$676 Hold
111
﹤0.01% 433
2025
Q4
$796 Hold
111
﹤0.01% 254
2025
Q3
$1.18K Sell
111
-4
-3% -$39 ﹤0.01% 250
2025
Q2
$1.12K Hold
115
﹤0.01% 235
2025
Q1
$1.71K Sell
115
-20
-15% -$308 ﹤0.01% 216
2024
Q4
$2K Buy
+135
New +$2.2K ﹤0.01% 248

Other funds holding OGN

Banque Transatlantique's OGN Position: Q2 2026 in Review

Banque Transatlantique increased its Organon & Co (OGN) stake by 54% in Q2 2026, buying an estimated $717 and bringing the position to 171 shares worth $1.75K. The position accounts for ﹤0.01% of the portfolio, ranked #479.

Banque Transatlantique first reported a position in OGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $2K in Q4 2024. 635 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Banque Transatlantique held 171 shares of Organon & Co worth $1.75K as of Q2 2026.
  • Banque Transatlantique bought 60 Organon & Co shares in Q2 2026, an estimated $717.
  • Organon & Co made up ﹤0.01% of Banque Transatlantique's portfolio in Q2 2026, its #479 holding.
  • Banque Transatlantique first reported a position in Organon & Co in Q4 2024 and has held it in 7 quarters since.
  • Banque Transatlantique's Organon & Co position peaked at $2K in Q4 2024.
  • 635 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Banque Transatlantique's 13F filing for Q2 2026, filed 30 Jul 2026.